Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
800 participants
OBSERVATIONAL
2024-04-01
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Registry Study of Biomarkers in Heart Valve Disease
NCT06223906
Prognostic Value of Myocardial Fibrosis in Severe Aortic Valve Stenosis
NCT03585933
European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study
NCT06235385
Valvular Heart Disease Registry Study in Second Affiliated Hospital of ZheJiang University
NCT03011697
Platelet Adhesion in the Pathobiology of Aortic Stenosis
NCT05550896
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with Valvular Heart Disease
Women with Valvular Heart Disease
No interventions assigned to this group
Men with Valvular Heart Disease
Men with Valvular Heart Disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission to the VHD-W Registry collaborating center.
Exclusion Criteria
* Inability to provide informed consent per local institutional and regulatory requirements.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Association of Cardiovascular Imaging
OTHER
Valvular Heart Disease in Women Registry
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julia Grapsa
Professor, Cardiovascular Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julia Grapsa, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Harvard Medical School (HMS and HSDM)
Ana G Almeida, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Lisbon University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aswan Heart Centre
Aswān, , Egypt
University of Lisbon
Lisbon, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VHD-W Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.